PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Size matters: Baby's size at birth may predict risk for disease later in life

New research in The FASEB Journal suggests that differences in DNA methylation patterns and long-term variation in gene activity established in the womb underpins the link between birth size and disease risk

2014-10-30
(Press-News.org) A new research report published in the November 2014 issue of The FASEB Journal suggests that being overweight might be better in the long term than being underweight. Before you reach for that box of Twinkies, however, it's important to note that this discovery only applies to the weight of newborn babies in relation to risk of future disease.

"These findings support the hypothesis that common long-term variation in the activity of genes established in the womb may underpin links between size at birth and risk for adult disease," said Claire R. Quilter, Ph.D., study author from the Mammalian Molecular Genetics Group, Department of Pathology at the University of Cambridge in the United Kingdom. "If confirmed these could be important markers of optimal fetal growth and may be the first step along a path to very early disease prevention in the womb."

Quilter and colleagues set out to determine whether or not there was any truth to the prevailing hypothesis that conditions in the womb that lead to a high birth weight or low birth weight could affect expression of genes in the baby, which in turn, leads to effects that persist into adult life. To do this, scientists looked at DNA derived from the cord blood of newborn babies from mothers with raised glucose levels during late pregnancy and in those babies born following relatively slow growth in the womb that later caught up after birth. Researchers looked for differences in DNA methylation patterns (chemical modifications of DNA known to effect changes in gene activity). Results showed differences in these methylation changes which were specific to boys and girls and to each of the two groups. However, changes were also identified that were common to both groups of babies. Similar overlapping signals were seen in two other groups of babies studied.

"In the age of epigenetics, prenatal care is moving beyond infant survival and into optimizing the health of the baby for his or her entire life," said Gerald Weissmann, M.D., Editor-in-Chief of The FASEB Journal. "Understanding the epigenetic factors that play a role in a baby's birthweight will eventually help doctors give the best care and advice to their pregnant patients."

INFORMATION: Receive monthly highlights from The FASEB Journal by e-mail. Sign up at http://www.faseb.org/fjupdate.aspx. The FASEB Journal is published by the Federation of the American Societies for Experimental Biology (FASEB). It is among the most cited biology journals worldwide according to the Institute for Scientific Information and has been recognized by the Special Libraries Association as one of the top 100 most influential biomedical journals of the past century.

FASEB is composed of 27 societies with more than 120,000 members, making it the largest coalition of biomedical research associations in the United States. Our mission is to advance health and welfare by promoting progress and education in biological and biomedical sciences through service to our member societies and collaborative advocacy.

Details: Claire R. Quilter, Wendy N. Cooper, Kerry M. Cliffe, Benjamin M. Skinner, Philippa M. Prentice, LaTasha Nelson, Julien Bauer, Ken K. Ong, Miguel Constância, William L. Lowe, Nabeel A. Affara, and David B. Dunger. Impact on offspring methylation patterns of maternal gestational diabetes mellitus and intrauterine growth restraint suggest common genes and pathways linked to subsequent type 2 diabetes risk. FASEB J. November 2014 28:4868-4879; doi:10.1096/fj.14-255240 ; http://www.fasebj.org/content/28/11/4868.abstract


ELSE PRESS RELEASES FROM THIS DATE:

New molecule sneaks medicines across the blood/brain barrier

2014-10-30
Delivering life-saving drugs across the blood-brain barrier (BBB) might become a little easier thanks to a new report published in the November 2014 issue of The FASEB Journal. In the report, scientists describe an antibody, called "FC5," is one-tenth the size of a traditional antibody and able to cross the BBB. Moreover, FC5 uses the same pathways as nutrients that the brain needs to survive, allowing it to "smuggle" larger antibodies across the barrier. Like a Lego building block, FC5 connects into many types of antibody designs, helping them reach their disease targets ...

Clock gene dysregulation may explain overactive bladder

2014-10-30
If you think sleep problems and bladder problems are a fact of life in old age, you may be right. A new report appearing in the November 2014 issue of The FASEB Journal, shows that our sleep-wake cycles are genetically connected to our bladder, and disruptions to one may cause problems with the other. This discovery builds on the hypotheses that under normal circumstances, a primary clock located in the brain controls several other peripheral clocks located throughout the body. These peripheral clocks, in turn, control the activity of functional proteins and receptors, ...

Patents for humanity: Special edition of Technology and Innovation

Patents for humanity: Special edition of Technology and Innovation
2014-10-30
TAMPA, Fla. (Oct. 30, 2014) – The current special issue of Technology and Innovation, is devoted to patents that benefit people around the world who live with limited resources, in challenging environments, and are in need of better access to basic needs and improved standards of living, health and infrastructure. The issue includes original articles from winners of the 2013 USPTO Patents for Humanity Awards, aimed at rewarding innovators for deploying patented technologies to address humanitarian needs. Winners featured in the issue include SIGN Fracture Care International, ...

Lou Gehrig's disease study: Renewing brain's aging support cells may help neurons survive

2014-10-30
LOS ANGELES (Oct. 29, 2014) – Lou Gehrig's disease, also known as amyotrophic lateral sclerosis, or ALS, attacks muscle-controlling nerve cells – motor neurons – in the brain, brainstem and spinal cord, leading to progressive weakness and eventual paralysis of muscles throughout the body. Patients typically survive only three to five years after diagnosis. Now, with publication of a study by investigators at the Cedars-Sinai Board of Governors Regenerative Medicine Institute, ALS researchers know the effects of the attack are worsened, at least in part, ...

Smithsonian scientist discovers populations of rare songbird in surprising new habitat

2014-10-30
The Swainson's warbler (Limnothlypis swainsonii) is one of the rarest and most secretive songbirds in North America, prized by birdwatchers in the southeastern U.S. hoping to catch a glimpse of it in the wild or hear its beautiful ringing song. With only 90,000 breeding individuals sparsely distributed across 15 states in the U.S., the Swainson's warbler is a species of high conservation concern that, for decades, has left conservationists with little confidence that its populations would ever be fully secure. However, new research published in the Oct. 30 edition of ...

National initiative shows multisystem approaches to reduce diabetes disparities

2014-10-30
Washington, DC – Exciting results from an innovative, multicultural, five-year initiative, known as the Alliance to Reduce Disparities in Diabetes (Alliance), have been published in ten peer-reviewed articles in the November 2014 supplemental issue of Health Promotion Practice (HPP). The findings reveal that a new model of chronic disease management for vulnerable populations with diabetes shows significant promise in strengthening coordination of care, reducing diabetes health disparities and improving health outcomes. Funded by Merck Foundation, the Alliance ...

Model by NIH grantees explains why HIV prevention dosing differs by sex

2014-10-30
WHAT: A mathematical model developed by NIH grantees predicts that women must take the antiretroviral medication Truvada daily to prevent HIV infection via vaginal sex, whereas just two doses per week can protect men from HIV infection via anal sex. This finding helps explain why two large clinical trials testing HIV pre-exposure prophylaxis, or PrEP, in women failed to show efficacy. Participants in the VOICE and FEM-PrEP trials of Truvada and tenofovir (another antiretroviral) for HIV prevention were counseled to take one of the medications daily. However, because they ...

Seeing dinosaur feathers in a new light

Seeing dinosaur feathers in a new light
2014-10-30
Why were dinosaurs covered in a cloak of feathers long before the early bird species Archaeopteryx first attempted flight? Researchers from the University of Bonn and the University of Göttingen attempt to answer precisely that question in their article "Beyond the Rainbow" in the latest issue of the renowned journal Science. The research team postulates that these ancient lizards had a highly developed ability to discern color. Their hypothesis: The evolution of feathers made dinosaurs more colorful, which in turn had a profoundly positive impact on communication, ...

The geometry of RNA

The geometry of RNA
2014-10-30
Messenger, transfer, ribosomal... there's more than one type of RNA. The difference lies not only in the sequence of the nucleotides, the "beads" that form the strand, but also in the three-dimensional structure that this long molecule takes on. Computer models are often used to reveal this structure but these tend to be rather complex, and they vary depending on the field of application. A team of SISSA scientists used numerical techniques to develop a new "geometrical" model which has the advantage of being much simpler and faster than those traditionally used as well ...

Cochrane Review of RDT for diagnosis of drug resistant TB

2014-10-30
Researchers from the Cochrane Infectious Diseases Group, hosted at LSTM, have conducted an independent review to examine the diagnostic accuracy of the GenoType® MTBDRsl assay for the detection of resistance to second-line anti-tuberculosis drugs. While there are a number of different drugs available to people suffering from tuberculosis (TB), resistance to these drugs is a growing problem. People suffering from a drug-resistant strain of TB are more likely to die from the disease, and require treatment with what are described as "second-line" drugs. These drugs can ...

LAST 30 PRESS RELEASES:

Individuals with multiple sclerosis face substantially greater risk of hospitalisation and death from COVID-19, despite high rates of vaccination

Study shows obesity in childhood associated with a more than doubling of risk of developing multiple sclerosis in early adulthood

Rice Emerging Scholars Program receives $2.5M NSF grant to boost STEM education

Virtual rehabilitation provides benefits for stroke recovery

Generative AI develops potential new drugs for antibiotic-resistant bacteria

Biofuels could help island nations survive a global catastrophe, study suggests

NJIT research team discovering how fluids behave in nanopores with NSF grant

New study shows association of historical housing discrimination and shortfalls in colon cancer treatment

Social media use may help to empower plastic surgery patients

Q&A: How to train AI when you don't have enough data

Wayne State University researchers uncover potential treatment targets for Zika virus-related eye abnormalities

Discovering Van Gogh in the wild: scientists unveil a new gecko species

Small birds spice up the already diverse diet of spotted hyenas in Namibia

Imaging detects transient “hypoxic pockets” in the mouse brain

Dissolved organic matter could be used to track and improve the health of freshwaters

Indoor air quality standards in public buildings would boost health and economy, say international experts

Positive associations between premenstrual disorders and perinatal depression

New imaging method illuminates oxygen's journey in the brain

Researchers discover key gene for toxic alkaloid in barley

New approach to monitoring freshwater quality can identify sources of pollution, and predict their effects

Bidirectional link between premenstrual disorders and perinatal depression

Cell division quality control ‘stopwatch’ uncovered

Vaccine protects cattle from bovine tuberculosis, may eliminate disease

Andrew Siemion to receive the SETI Institute’s 2024 Drake Award

New study shows how the Crimean-Congo hemorrhagic fever virus enters our cells

Neoadjuvant chemotherapy proves effective for locally advanced penile squamous cell carcinoma

Study flips treatment paradigm in bilateral Wilms tumor, shows resistance to chemotherapy may point toward favorable outcomes

Doctors received approximately $12.1 billion from drug and device makers between 2013-2022

Discovery suggests new strategy against follicular lymphoma

Making the future too bright: how wishful thinking can point us in the wrong direction

[Press-News.org] Size matters: Baby's size at birth may predict risk for disease later in life
New research in The FASEB Journal suggests that differences in DNA methylation patterns and long-term variation in gene activity established in the womb underpins the link between birth size and disease risk